Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding IBRN?
Track your performance easily
IBRN Price & Analysis
IBRN ETF Chart & Stats
Day’s Range― - ―
52-Week Range$19.08 - $26.90
Previous Close$23.78
VolumeN/A
Average Volume (3M)525.00
AUM3.64M
NAV23.81
Expense Ratio0.47%
Holdings Count55
Beta0.96
Inception DateAug 24, 2022
Last Dividend Ex-Date
Dec 20, 2023Dividend Yield
0.01 (―)Shares Outstanding200,000
Standard Deviation0.07
10 Day Avg. Volume68
30 Day Avg. Volume525
Alpha-0.00920
iShares Neuroscience and Healthcare ETF (IBRN) Fund Flow Chart
iShares Neuroscience and Healthcare ETF (IBRN) 1 year Net Flows: -$1M
IBRN ETF News
PremiumCompany Announcements
Xenon Pharmaceuticals to Highlight Advances at Health Care Conference
PremiumCompany Announcements
Argenx Shareholders Approve Key ResolutionsIBRN ETF FAQ
What was IBRN’s price range in the past 12 months?
IBRN lowest ETF price was $19.07 and its highest was $26.90 in the past 12 months.
What is the AUM of IBRN?
As of May 08, 2024 The AUM of IBRN is 3.64M.
Is IBRN overvalued?
According to Wall Street analysts IBRN’s price is currently Undervalued.
Does IBRN pay dividends?
IBRN pays a Notavailable dividend of <$0.01 which represents an annual dividend yield of N/A. See more information on IBRN dividends here
How many shares outstanding does IBRN have?
IBRN has 200,000 shares outstanding.
Which hedge fund is a major shareholder of IBRN?
Currently, no hedge funds are holding shares in IBRN
IBRN ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Neurocrine Biosciences
4.93%
Sarepta Therapeutics Inc.
4.79%
Cerevel Therapeutics Holdings Inc
4.66%
Argenx
4.59%
Intra-Cellular Therapies
4.51%
PTC Therapeutics
4.50%
Axonics Modulation Technologies
4.50%
Biogen Inc.
4.48%
Xenon Pharmaceuticals
4.20%
Biohaven Ltd.
3.79%
Total44.96%
ETF Description
iShares Neuroscience and Healthcare ETF
IBRN tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.